CONTRACT AWARD ID

$28,728,000

PRINCETON BIOMEDITECH CORP

Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response · FY2025

Minority-Owned
Award ID: 75A50223C00045 Full record on USAspending.gov →
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
NAICS Code
325413: IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Fiscal Year
FY2025
Period of Performance
Sept. 20, 2023 – March 19, 2025
Place of Performance
NJ
Recipient UEI
KWPPNEUVY865

Contract Description

OVER THE COUNTER (OTC) COVID-19 TESTS

Set-aside / business type

USAspending records these business types for the recipient on this award. They describe the firm when the award was made; on their own they do not show which set-aside, if any, the contract was competed under. The full record on USAspending.gov carries the type of set-aside.

How to compete for similar contracts

IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (NAICS 325413) contracts from Department of Health and Human Services come up again as new solicitations on SAM.gov. This recipient was recorded as Minority-Owned on this award.

Similar awards: Department of Health and Human Services, NAICS 325413

Other contracts awarded to PRINCETON BIOMEDITECH CORP

Data sourced from USASpending.gov. Award amounts reflect total contract obligation at time of sync. Certification flags reflect recipient-reported business type at time of award.